Literature DB >> 9666905

Early detection of changes in visual function in diabetes mellitus.

G M Ismail1, D Whitaker.   

Abstract

Psychophysical measurements were performed with a view to providing an assessment of early neural functional integrity in the presence of no or minimal diabetic retinopathy (DR). The investigations were carried out on a normal group and a number of age- and sex-matched non-insulin dependent diabetic groups with different levels of DR. Results were considered in terms of the presence of functional changes relative to the severity of DR and the duration of diabetes. Significant deficits were found for visual acuity (VA), contrast sensitivity (CS) and colour vision. Both CS and colour vision measurements differentiated between non-diabetics and those with diabetes but without DR. However, none of the tests reliably distinguished diabetics without DR from those with early retinal changes although VA and colour vision (especially along a blue-yellow colour axis) were sensitive to more substantial retinal changes. This finding suggests such tests may be useful as screening tests for more advanced levels of background DR.

Entities:  

Mesh:

Year:  1998        PMID: 9666905

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  17 in total

1.  Bayesian adaptive estimation of the contrast sensitivity function: the quick CSF method.

Authors:  Luis Andres Lesmes; Zhong-Lin Lu; Jongsoo Baek; Thomas D Albright
Journal:  J Vis       Date:  2010-03-30       Impact factor: 2.240

2.  Global flash multifocal electroretinogram: early detection of local functional changes and its correlations with optical coherence tomography and visual field tests in diabetic eyes.

Authors:  J C Y Lung; P G Swann; D S H Wong; H H L Chan
Journal:  Doc Ophthalmol       Date:  2012-07-25       Impact factor: 2.379

Review 3.  The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy.

Authors:  Alistair J Barber; Thomas W Gardner; Steven F Abcouwer
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-28       Impact factor: 4.799

4.  Decreased optical coherence tomography-measured pericentral retinal thickness in patients with diabetes mellitus type 1 with minimal diabetic retinopathy.

Authors:  Carine Biallosterski; Mirjam E J van Velthoven; Robert P J Michels; Reinier O Schlingemann; J Hans DeVries; Frank D Verbraak
Journal:  Br J Ophthalmol       Date:  2007-03-23       Impact factor: 4.638

5.  Retinal structure-function correlation in type 2 diabetes.

Authors:  Sangeetha Srinivasan; Ramachandran Rajalakshmi; Ranjit Mohan Anjana; Rayaz A Malik; Vaitheeswaran Kulothungan; Rajiv Raman
Journal:  Eye (Lond)       Date:  2021-08-30       Impact factor: 4.456

6.  Short-wavelength automated perimetry in patients with diabetes mellitus without macular edema.

Authors:  Andreas Remky; Anke Weber; Stefan Hendricks; Kristina Lichtenberg; Oliver Arend
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-05-17       Impact factor: 3.117

7.  Color vision deficiency in preschool children: the multi-ethnic pediatric eye disease study.

Authors:  John Z Xie; Kristina Tarczy-Hornoch; Jesse Lin; Susan A Cotter; Mina Torres; Rohit Varma
Journal:  Ophthalmology       Date:  2014-03-16       Impact factor: 12.079

Review 8.  Photoreceptor cells and RPE contribute to the development of diabetic retinopathy.

Authors:  Deoye Tonade; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2020-11-12       Impact factor: 19.704

9.  Changes in frequency-doubling perimetry in patients with type I diabetes prior to retinopathy.

Authors:  Isabel Pinilla; Antonio Ferreras; Miriam Idoipe; Ana I Sanchez-Cano; Diana Perez-Garcia; Laura X Herrera; Maria J Pinilla; Emilio Abecia
Journal:  Biomed Res Int       Date:  2013-11-11       Impact factor: 3.411

Review 10.  A critical review: Psychophysical assessments of diabetic retinopathy.

Authors:  Xing D Chen; Thomas W Gardner
Journal:  Surv Ophthalmol       Date:  2020-08-29       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.